Drug Naming
OTC Brand Name Confusion 04/07/2015 Reapproved | AMCP is concerned that a distinct brand name on an OTC product does not always refer to the same active ingredient(s). This inconsistent relationship between brand name and ingredients may be confusing to some patients and may lead to medication errors and adverse events. AMCP believes that the naming approach should be changed to avoid this confusion. In conjunction with pharmacists, physicians, and other health care professionals, product names and packaging should be adopted and designed to minimize confusion and prevent adverse outcomes. |
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
